Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
In vivo imaging of the structure and metabolic function of huma retina and retinal pigment epithelium at the cellular level
Author Affiliations & Notes
  • Xiaolin Wang
    Doheny Eye Institute, Los Angeles, California, United States
  • Ruixue Liu
    Doheny Eye Institute, Los Angeles, California, United States
  • SriniVas R Sadda
    Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Yuhua Zhang
    Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Xiaolin Wang None; Ruixue Liu None; SriniVas Sadda Amgen, Allergan, Genentech/Roche, Iveric, Oxurion, Novartis, Regeneron, Bayer, 4DMT, Centervue, Heidelberg, Optos, Merck, Apellis, Astellas, Code C (Consultant/Contractor), Nidek, Topcon, Heidelberg, Carl Zeiss Meditec, Optos, Centervue, Code F (Financial Support); Yuhua Zhang Senju Pharmaceutical Co., Ltd., Code R (Recipient)
  • Footnotes
    Support  : NIH R01EY024378, R01EY03421, W. F. Keck Foundation, Carl Marshall Reeves & Mildred Almen Reeves Foundation, Research to Prevent Blindness/Dr. H. James and Carole Free Catalyst Award for Innovative Research Approaches for AMD.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2173. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Xiaolin Wang, Ruixue Liu, SriniVas R Sadda, Yuhua Zhang; In vivo imaging of the structure and metabolic function of huma retina and retinal pigment epithelium at the cellular level. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2173.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To design adaptive optics enhanced fluorescence lifetime imaging ophthalmoscopy (AOFLIO) that can image the retinal structure and metabolic function at the cellular level and optimize AOFLIO photon detection.

Methods : A picosecond diode laser (λ = 473 nm, pulse width 40 ps) was employed to excite the endogenous fluorophores in the retina and RPE in the living human eye. The autofluorescence lifetime was measured in a long spectral channel (LSC: 560 - 720 nm) and a short spectral channel (SSC: 500 - 560 nm) using the time-correlated single photon counting (TCSPC) method through an adaptive optics confocal scanning imaging system. A high-precision timing system generated the line and frame synchronization signals and the pixel clock by using a phase-locked loop to track the motion of the fast scanner, enabling the fluorescence lifetime to be measured across the 2D scanning field in a FIFO imaging mode. The retinal movement was calculated from the consecutive adaptive optics high-resolution confocal images of the same retinal area simultaneously acquired with the fluorescence lifetime measurement using a near-infrared light source (λ = 790 nm), ensuring precise registration of autofluorescence photons recorded in successive frames. The thresholds of the constant fraction discriminators and the time to amplitude converters of the photodetectors were optimized to ensure maximum photon detection. Under the safe light exposure limits, AOFLIO images acquired with laser pulse repetition rates at 80, 50, and 20 MHz were evaluated to assess the excitation efficiency.

Results : Adaptive optics increased the photon number by 2.0 times in the LSC and 1.7 times in the SSC. AOFLIO produced high-resolution retinal autofluorescence lifetime images, rendering clear RPE cell structure, and indicating an inhomogeneous distribution of multiple fluorophores associated with specific metabolic states at the cellular level.

Conclusions : High-resolution AOFLIO can precisely measure the retinal and RPE metabolic function and potentially characterize the distribution of different intrinsic fluorophores in the human retina and RPE at the cellular level. It can inform the interpretation of clinical FLIO imaging and improve the biological bases of retinal and RPE functions for next-generation imaging technology.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×